Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Activation, Patient”

1,209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,209 results

Not applicableStudy completedNCT00026000
What this trial is testing

Brain Activation in Vocal and Motor Tics

Who this might be right for
Tourette's SyndromeChronic Motor Tic DisorderChronic Motor Vocal Disorder
National Institute of Neurological Disorders and Stroke (NINDS) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Looking for participantsNCT07755397
What this trial is testing

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Who this might be right for
NSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck
Jubilant Therapeutics India Limited 30
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Not applicableWithdrawnNCT02529098
What this trial is testing

Modification in Cortical Activation in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation

Who this might be right for
Vision Disorders
University Hospital, Toulouse
Not applicableStudy completedNCT05574621
What this trial is testing

ITA Vs LAD; Evaluation of Inflammatory Burden in OP-CABG Patients

Who this might be right for
Ischemic Heart DiseaseCoronary Artery DiseaseAtherosclerosis+1 more
Cardiochirurgia E.H. 20
Not applicableStudy completedNCT03812614
What this trial is testing

Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support

Who this might be right for
Diabetes MellitusHigh Blood PressureHigh Blood Sugar+1 more
University of Pittsburgh 444
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Not applicableStudy completedNCT00071370
What this trial is testing

Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients With Non-Diagnostic EEG

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 25
Not applicableEnrolling By InvitationNCT06358261
What this trial is testing

Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool

Who this might be right for
PreDiabetesLifestyle, HealthyActivation, Patient
Johns Hopkins University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT02478957
What this trial is testing

Treatment of Indolent Systemic Mastocytosis With PA101

Who this might be right for
MastocytosisSystemic MastocytosisIndolent Systemic Mastocytosis
Patara Pharma 41
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Testing effectiveness (Phase 2)Ended earlyNCT01981187
What this trial is testing

LGX818 for Patients With BRAFV600 Mutated Tumors

Who this might be right for
Solid TumorHematologic Malignancies
Pfizer 12
Very early researchLooking for participantsNCT06898437
What this trial is testing

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Early research (Phase 1)Study completedNCT00001112
What this trial is testing

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07629167
What this trial is testing

Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

Who this might be right for
Acneiform Drug EruptionAcneiform Eruptions
University of California, San Francisco 50
Testing effectiveness (Phase 2)Study completedNCT02394730
What this trial is testing

Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints

Who this might be right for
HIV
Kirby Institute 65
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Next Page